Generali Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$986K Sell
11,656
-19,844
-63% -$1.6M 0.02% 339
2026
Q1
$2.23M Buy
31,500
+5,145
+20% +$385K 0.05% 277
2025
Q4
$2.08M Sell
26,355
-1,720
-6% -$136K 0.04% 295
2025
Q3
$2.31M Buy
28,075
+7,272
+35% +$572K 0.05% 276
2025
Q2
$1.67M Buy
20,803
+14,886
+252% +$1.15M 0.04% 345
2025
Q1
$475K Buy
5,917
+225
+4% +$18.7K 0.01% 420
2024
Q4
$466K Buy
+5,692
New +$474K 0.01% 402

Other funds holding MET

Generali Asset Management's MET Position: Q2 2026 in Review

Generali Asset Management reduced its MetLife (MET) stake by 63% in Q2 2026, selling an estimated $1.6M and leaving 11,656 shares worth $986K. The position accounts for 0.02% of the portfolio, ranked #339.

Generali Asset Management first reported a position in MET in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.31M in Q3 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Generali Asset Management held 11,656 shares of MetLife worth $986K as of Q2 2026.
  • Generali Asset Management sold 19,844 MetLife shares in Q2 2026, an estimated $1.6M.
  • MetLife made up 0.02% of Generali Asset Management's portfolio in Q2 2026, its #339 holding.
  • Generali Asset Management first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's MetLife position peaked at $2.31M in Q3 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.